Patents by Inventor Elizabeth Ann KILLION

Elizabeth Ann KILLION has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNAI CONSTRUCTS AND METHODS FOR INHIBITING FAM13A EXPRESSION
    Publication number: 20240084301
    Abstract: The present application relates to compositions and methods for modulating expression of Family with Sequence Similarity 13 Member A (FAM13A) protein. In particular, the present application relates to nucleic acid-based therapeutics for reducing FAM13A gene expression via RNA interference and methods of using such nucleic acid-based therapeutics to reduce abdominal adiposity, reduce body weight, reduce fat mass, improve metabolic parameters including insulin resistance and non-alcoholic steatohepatitis (NASH), and reduce risk of myocardial infarction.
    Type: Application
    Filed: July 24, 2023
    Publication date: March 14, 2024
    Applicant: AMGEN INC.
    Inventors: Elizabeth Ann KILLION, Jerry Ryan HOLDER, Bryan MEADE, Justin K. MURRAY, Oliver R. HOMANN, Briana Renee GRIEGO, Murielle Marie VENIANT ELLISON
  • METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)
    Publication number: 20220403038
    Abstract: Methods of treating diseases and disorders characterized by elevated levels of cortisol using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments the disease or disorder is Cushing's syndrome.
    Type: Application
    Filed: November 9, 2020
    Publication date: December 22, 2022
    Inventors: David John LLOYD, Elizabeth Ann KILLION, Glenn N. SIVITS, JR.